Form D Explorer

Form C-AR — Rejuve Biotech Inc.

0001669191-25-000296 · filed 2025-04-30

Offering

Target
Maximum
Security type
Price per security
Deadline
Oversubscription

Issuer

CIK
1994911
Entity
Corporation
Jurisdiction
CA
Address
215 S Orange St
ORANGE, CA 92866
Phone

Most recent fiscal year financials

Total assets
$257,811
Cash
Short-term debt
Long-term debt
Revenues
COGS
Taxes paid
Net income
$-13,513

View original on SEC EDGAR.